Effectiveness and tolerability of fludarabine and busulfan conditioning regimen in patients with acute myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation

Trial Profile

Effectiveness and tolerability of fludarabine and busulfan conditioning regimen in patients with acute myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Nov 2015

At a glance

  • Drugs Fludarabine (Primary) ; Antithymocyte globulin; Busulfan
  • Indications Acute myeloid leukaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top